Table 4. Clinical characteristics of the finnish diabetes prevention study (DPS, n=122).
| Baseline | 1 year | P-value | |
|---|---|---|---|
| Sex (men/women) | 28/94 | ||
| Intervention/Control group | 87/35 | ||
| Age (years) | 54.3±7.1 | ||
| Weight (kg) | 88.8±14.7 | 81.4±13.7 | <0.001 |
| Body mass index (kg m−2) | 32.2±4.6 | 29.5±4.2 | <0.001 |
| Fasting Insulin (mU l−1) | 14.8±7.7 | 12.6±10.3 | <0.05 |
| Fasting glucose (mmol l−1) | 6.1±0.5 | 5.8±0.6 | <0.001 |
| Total cholesterol (mmol l−1) | 5.5±0.8 | 5.4±0.9 | <0.05 |
| LDL cholesterol (mmol l−1) | 3.5±0.7 | 3.4±0.8 | >0.05 |
| HDL cholesterol (mmol l−1) | 1.2±0.3 | 1.3±0.3 | <0.001 |
| Triglycerides (mmol l−1) | 1.7±0.8 | 1.4±0.6 | <0.001 |
Values are presented as mean±s.d.
Statistically significant changes in bold (P<0.05 in paired samples t-test).